arx305,arx517
ambrx
['arx305', 'arx517', 'ambrx']
ambrx announced new preclinical data on arx517 and arx305 at the 2023 annual meeting. for details: $amam #aacr23 
Ambrx (Nasdaq: $AMAM) is developing a pipeline of Engineered Precision Biologics as treatments for cancer indications with a high unmet medical need.